Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FlyteHealth vs Ozari Health

FlyteHealth
Graded #363

Lower grade

vs+11.199999999999996
Ozari Health
Graded #117

Higher grade

The verdict

Ozari Health takes it — 69.8/100 to 58.6/100.

Ozari Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ozari Health is a telehealth weight-loss platform offering physician-prescribed compounded GLP-1 from licensed pharmacies — semaglutide from $86/month and tirzepatide from around $149/month, with shipping…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOzari Health +39
45
84
Dose & formulationOzari Health +24
40
64
Clinical oversightFlyteHealth +4
83
79
Labs & monitoringFlyteHealth +21
73
52
FulfillmentOzari Health +5
62
67
Contract termsEven
55
55
FlyteHealth · left barOzari Health · right bar

The numbers

MetricFlyteHealthOzari Health
WeighScore58.6/10069.8/100
GradeCC
Scorecard rank#363#117
SemaglutideNot disclosed$86/mo (compounded)
TirzepatideNot disclosed$149/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
FlyteHealth

Graded #363 · C

Strengths

  • Care led by board-certified obesity-medicine physicians
  • Multidisciplinary team with NPs, dietitians, and care coordinators
  • Published outcomes of about 13 to 16 percent weight loss over 12 months
  • High GLP-1 medication adherence (around 86 percent in reported data)
  • Comprehensive cardiometabolic care beyond GLP-1 alone

Where it loses points

  • Distributed primarily via employers, payers, and health plans, not direct cash-pay
  • Access is largely gated behind employer or plan sponsorship
  • GLP-1 is prescribed only when appropriate, not guaranteed
  • Self-pay pricing is not publicly listed (contact required)
  • Less suited to consumers wanting fast direct-to-door GLP-1
Ozari Health

Graded #117 · C

Strengths

  • Very low entry pricing — compounded semaglutide from $86/month
  • LegitScript certified and operated by a named entity (Ozari LLC)
  • Board-certified physicians; meds compounded in 503A and 503B facilities
  • Shipping included in the plan price

Where it loses points

  • Doesn't clearly list which states it serves or name its pharmacies
  • Tirzepatide and higher semaglutide doses cost more than the $86 headline
  • Compounded semaglutide and tirzepatide only — no brand-name options
  • Newer, lighter web presence than established competitors

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard